Studie 1 var en icke- jämförande studie med 54 patienter med recidiverande follikulärt lymfom, refraktärt mot rituximab- behandling. ###>Study 1 was a single arm study of 54 patients with relapsed follicular lymphoma refractory to rituximab treatment.